Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
暂无分享,去创建一个
D. Pe’er | M. Ladanyi | M. Kris | M. Arcila | Gregory Riely | R. Somwar | N. Rekhtman | P. Paik | M. Davare | J. Chan | M. Offin | H. Rizvi | Helena A. Yu | U. Shinde | Y. Daneshbod | A. Schoenfeld | Daisuke Kubota | Jason C. Chang | Hiroki Sato | H. Yu